Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9578 posts found.

tablets_red

Take the Pharmafocus reader survey today

November 23, 2015 Manufacturing and Production, Research and Development

As a valued reader of Pharmafocus, you regularly receive print copies of our market-leading newspaper and have access to the digital …
Feature
pfizer_hq_new_york_dark

Pfizer and Allergan confirm record $160 billion merger

November 23, 2015 Manufacturing and Production, Research and Development

Pfizer and Allergan have confirmed a $160 billion merger, unanimously approved by their boards of directors, creating the world’s largest …
News
Takeda oncology

FDA approves Takeda’s Ninlaro for multiple myeloma

November 23, 2015 Manufacturing and Production, Research and Development Takeda, myeloma

The US Food and Drug Administration (FDA) has approved Takeda’s Ninlaro (ixazomib) for use in combination with lenalidomide and dexamethasone …
News
cosentyx_logo

Novartis bags two EU Cosentyx approvals

November 23, 2015 Research and Development, Sales and Marketing

The European Commission (EC) has approved Novartis’ Cosentyx (secukinumab) for the treatment of people living with ankylosing spondylitis (AS) and …
News
amgen_flag

European Commission approves Amgen’s cancer drug Kyprolis in combo therapy

November 20, 2015 Research and Development, Sales and Marketing

The European Commission (EC) has today granted marketing authorization for Amgen’s Kyprolis (carfilzomib) in combination with lenalidomide and dexamethasone for …
News
ema_logo

Bioproject’s narcolepsy treatment recommended for European approval

November 20, 2015 Research and Development, Sales and Marketing

The European Medicines Agency (EMA) has recommended granting a marketing authorisation for Bioproject’s Wakix (pitolisant) for the treatment of narcolepsy …
News
ema_inside

Biogen’s Enbrel biosimilar gets positive CHMP opinion

November 20, 2015 Research and Development, Sales and Marketing

The Committee for Medicinal Products for Human Use (CHMP) today gave a positive opinion to Benepali- the first biosimilar version …
News
martin_shkreli_smaller_same

Turing boss Shkreli joins KaloBios as CEO; takes 70% of shares

November 20, 2015 Medical Communications, Research and Development

KaloBios Pharmaceuticals has announced the appointment of Turing CEO Martin Shkreli as its own new CEO and his election as …
Appointment
dr_allan_dunton

Alan Dunton appointed senior vice president at Purdue Pharma

November 20, 2015 Manufacturing and Production, Medical Communications, Research and Development

Purdue Pharma LP has announced the appointment of Alan Dunton, MD, to the role of senior vice president of Research …
Appointment
keytruda

Lilly and Merck extend immuno-oncology collaboration

November 20, 2015 Medical Communications, Research and Development Eli Lilly, Merck

Eli Lilly and Merck have announced the extension of their existing collaboration to evaluate the safety and efficacy of the …
News
bayercross3

Bayer awaits FDA decision on new contraceptive

November 20, 2015 Medical Communications, Research and Development

Bayer has submitted a new drug application (NDA) to the FDA, seeking approval for LCS-16, an investigational hormonal intrauterine device …
News
nhs_england_and_nice_logos

NHS England and NICE announce plans for new Cancer Drugs Fund

November 19, 2015 Medical Communications, Research and Development Cancer Drugs Fund, NHS England, NICE

A 12-week consultation on draft proposals for a revamped Cancer Drugs Fund (CDF) has been launched by NHS England and NICE, …
News
bayer_cross_2

NICE decision restricts Bayer’s Xofigo to select prostate cancer patients

November 19, 2015 Research and Development, Sales and Marketing Bayer, NICE, prostate cancer

NICE has issued its Final Appraisal Determination (FAD) recommending Bayer’s Xofigo (radium-223 dichloride) for use on the NHS in England …
News
nice

Merck criticises NICE ‘no’ to personalised bowel cancer drugs

November 19, 2015 Research and Development

NICE has issued preliminary not recommending two specific personalised treatments used in combination with chemotherapy for previously untreated metastatic colorectal …
News

NICE rejects Amgen’s Repatha in draft guidance

November 18, 2015 Research and Development, Sales and Marketing Amgen, NICE, Repatha, evolocumab, high cholesterol

NICE has published draft guidance rejecting Amgen’s Repatha as a treatment for people with high cholesterol.   
News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026